Publications by authors named "F C Guma"

Article Synopsis
  • The cystatin superfamily is vital for inhibiting cysteine proteases, which are involved in important biological functions like seed development and disease resistance in plants, and tumor progression in humans.
  • A novel rice-derived chimeric legumain inhibitor was evaluated through simulations and laboratory tests, showing strong stability and affinity for the legumain enzyme.
  • The study indicates that the chimeric Oryzacystatin I mutant could be a valuable candidate for developing new cancer treatments due to its effectiveness in reducing tumor cell migration and viability.
View Article and Find Full Text PDF

Androgen independent phase in prostate cancer (PCa) commonly limits the therapeutic efficacy. through its main active compound, α-thujone, appears to be an option, considering its anti-proliferative, anti-metastatic and pro-apoptotic effects on hepatocellular carcinoma. However, studies on PCa are limited.

View Article and Find Full Text PDF

Hypercholesterolemia has been associated with cognitive dysfunction and neurodegenerative diseases. Moreover, this metabolic condition disrupts the blood-brain barrier, allowing low-density lipoprotein (LDL) to enter the central nervous system. Thus, we investigated the effects of LDL exposure on mitochondrial function in a mouse hippocampal neuronal cell line (HT-22).

View Article and Find Full Text PDF

The fundamental goal of this research is to suggest a novel mathematical operator for modeling visceral leishmaniasis, specifically the Caputo fractional-order derivative. By utilizing the Fractional Euler Method, we were able to simulate the dynamics of the fractional visceral leishmaniasis model, evaluate the stability of the equilibrium point, and devise a treatment strategy for the disease. The endemic and disease-free equilibrium points are studied as symmetrical components of the proposed dynamical model, together with their stabilities.

View Article and Find Full Text PDF

Background: Skeletal muscle synthesizes, stores, and releases body L-glutamine (GLN). Muscle atrophy due to disabling diseases triggers the activation of proteolytic and pro-apoptotic cell signaling, thus impairing the body's capacity to manage GLN content. This situation has a poor therapeutic prognosis.

View Article and Find Full Text PDF